{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:49:19Z","timestamp":1792054159618,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.psychres.2026.117283","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:34:19Z","timestamp":1781541259000},"page":"117283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patterns of onset and progression of psychoses induced by psychoactive substance use"],"prefix":"10.1016","volume":"364","author":[{"given":"Petru","family":"Ifteni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8697-1945","authenticated-orcid":false,"given":"Ana Aliana","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Necula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Dima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Teodorescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117283_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnsyn.2014.00019","article-title":"Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release","volume":"6","author":"Acevedo-Rodriguez","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.psychres.2026.117283_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.913965","article-title":"Bipolar disorder and polysubstance use disorder: sociodemographic and clinical correlates","volume":"13","author":"Aguglia","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"14","key":"10.1016\/j.psychres.2026.117283_bib0003","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1017\/S0033291717001118","article-title":"Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study","volume":"47","author":"Alderson","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2026.117283_bib0004","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.psychres.2026.117283_bib0005","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.psychres.2026.117283_bib0006","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1017\/S0033291724002058","article-title":"The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies","volume":"54","author":"Austin-Zimmerman","year":"2024","journal-title":"Psychol. Med."},{"issue":"5\u20136","key":"10.1016\/j.psychres.2026.117283_bib0007","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/09540261.2023.2261544","article-title":"Managing drug-induced psychosis","volume":"35","author":"Balda\u00e7ara","year":"2023","journal-title":"Int. Rev. Psychiatry"},{"issue":"7629","key":"10.1016\/j.psychres.2026.117283_bib0008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of \u03949-tetrahydrocannabinol on the dopamine system","volume":"539","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.psychres.2026.117283_bib0009","first-page":"168","article-title":"Forensic considerations of substance-induced psychosis","volume":"41","author":"Bourget","year":"2013","journal-title":"J. Am. Acad. Psychiatry Law"},{"key":"10.1016\/j.psychres.2026.117283_bib0010","series-title":"Substance Use and the Acute Psychiatric Patient","article-title":"Substance-induced psychosis and Co-occurring psychotic disorders","author":"Brown","year":"2019"},{"issue":"11","key":"10.1016\/j.psychres.2026.117283_bib0011","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/17425255.2022.2147425","article-title":"Drug-drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs","volume":"18","author":"Buzea","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117283_bib0012","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.62.2.137","article-title":"Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses","volume":"62","author":"Caton","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117283_bib0013","first-page":"1","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"Perm J."},{"issue":"1","key":"10.1016\/j.psychres.2026.117283_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0376-8716(03)00064-4","article-title":"Testing hypotheses about the relationship between cannabis use and psychosis","volume":"71","author":"Degenhardt","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis","volume":"195","author":"Di Forti","year":"2009","journal-title":"Br J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117283_bib0016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/cells12040577","article-title":"Short- and long-term effects of cocaine on enteric neuronal functions","volume":"12","author":"Elfers","year":"2023","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.psychres.2026.117283_bib0017","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/add.70014","article-title":"Relapse in substance-induced psychosis and associated risk factors. A nationwide register-linkage study from Sweden","volume":"120","author":"Ellil\u00e4","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.psychres.2026.117283_bib0019","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fpsyt.2019.00740","article-title":"Antipsychotics for amphetamine psychosis","volume":"10","author":"Fluyau","year":"2019","journal-title":"A System. Rev. Front. Psychiatry."},{"issue":"1","key":"10.1016\/j.psychres.2026.117283_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/a0034761","article-title":"Reasons for substance use and their relationship to subclinical psychotic and affective symptoms, coping, and substance use in a nonclinical sample","volume":"28","author":"Gregg","year":"2014","journal-title":"Psychol. Addict. Behav."},{"issue":"Pt 6","key":"10.1016\/j.psychres.2026.117283_bib0021","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"Iversen","year":"2003","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.psychres.2026.117283_bib0022","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1176\/appi.ajp.2019.18101217","article-title":"Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample","volume":"176","author":"Kendler","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117283_bib0023","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1523\/JNEUROSCI.4336-13.2014","article-title":"Cocaine dysregulates opioid gating of GABA neurotransmission in the ventral pallidum","volume":"34","author":"Kupchik","year":"2014","journal-title":"J. Neurosci."},{"issue":"9831","key":"10.1016\/j.psychres.2026.117283_bib0024","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.psychres.2026.117283_bib0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s13311-015-0382-6","article-title":"Cannabinoids and schizophrenia: risks and therapeutic potential","volume":"12","author":"Manseau","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.psychres.2026.117283_bib0026","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2026.117283_bib0027","series-title":"Cannabinoids and the Brain","article-title":"Anatomical distribution of receptors, ligands and enzymes in the brain and in the spinal cord: circuitries and neurochemistry","author":"Marsicano","year":"2008"},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0028","first-page":"e525","article-title":"Xanomeline\/Trospium (Cobenfy): a novel approach for the treatment of schizophrenia in adults","volume":"32","author":"Miron","year":"2025","journal-title":"Am. J. Ther."},{"issue":"8","key":"10.1016\/j.psychres.2026.117283_bib0029","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamapsychiatry.2020.0339","article-title":"Will legalization and commercialization of cannabis use increase the incidence and prevalence of psychosis?","volume":"77","author":"Murray","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117283_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/schbul\/sbz102","article-title":"Transition of substance-induced, brief, and Atypical psychoses to schizophrenia: a systematic review and meta-analysis","volume":"46","author":"Murrie","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2026.117283_bib0031","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1192\/bjp.2025.72","article-title":"Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis","volume":"228","author":"Mustonen","year":"2025","journal-title":"Br J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0032","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/IJPSYM.IJPSYM_164_18","article-title":"Comorbidity of personality disorder among Substance Use disorder patients: a narrative review","volume":"40","author":"Parmar","year":"2018","journal-title":"Indian J. Psychol. Med."},{"issue":"3","key":"10.1016\/j.psychres.2026.117283_bib0033","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/MJT.0000000000001120","article-title":"A systematic review of clinical studies on the effect of psychoactive cannabinoids in psychiatric conditions in Alzheimer dementia","volume":"27","author":"Paunescu","year":"2020","journal-title":"Am J. Ther."},{"issue":"11","key":"10.1016\/j.psychres.2026.117283_bib0034","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/mp.2014.51","article-title":"Genetic predisposition to schizophrenia associated with increased use of cannabis","volume":"19","author":"Power","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/antiox13060709","article-title":"The underlying neurobiological mechanisms of psychosis: focus on neurotransmission dysregulation, neuroinflammation, oxidative stress, and mitochondrial dysfunction","volume":"13","author":"Rawani","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.psychres.2026.117283_bib0036","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/healthcare12030339","article-title":"Third-generation antipsychotics and lurasidone in the treatment of substance-induced psychoses: a narrative review","volume":"12","author":"Ricci","year":"2024","journal-title":"Healthcare"},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0037","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1176\/appi.ajp.22010076","article-title":"Transition from substance-induced psychosis to Schizophrenia spectrum disorder or bipolar disorder","volume":"180","author":"Rognli","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0038","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1360-0443.2011.03760.x","article-title":"Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years","volume":"107","author":"R\u00f6ssler","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.psychres.2026.117283_bib0039","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09540260902782802","article-title":"Cannabinoids and psychosis","volume":"21","author":"Sewell","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117283_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320967197","article-title":"New psychoactive substances: a review and updates","volume":"10","author":"Shafi","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117283_bib0041","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41401-024-01472-9","article-title":"Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery","volume":"46","author":"Shen","year":"2025","journal-title":"Acta Pharmacol. Sin"},{"issue":"3","key":"10.1016\/j.psychres.2026.117283_bib0042","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.comppsych.2008.07.009","article-title":"Prevalence of psychotic symptoms in substance users: a comparison across substances","volume":"50","author":"Smith","year":"2009","journal-title":"Compr. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117283_bib0043","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and predictors of conversion to Schizophrenia or bipolar disorder following substance-induced psychosis","volume":"175","author":"Starzer","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2026.117283_bib0044","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1093\/schbul\/sbaa029.641","article-title":"Multiple drug use in Schizophrenia - the role of early environmental risk accumulation and genetic predisposition","volume":"46","author":"Steixner-Kumar","year":"2020","journal-title":"Schizophr Bull."},{"issue":"11","key":"10.1016\/j.psychres.2026.117283_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11920-023-01452-6","article-title":"The Co-occurrence of personality disorders and substance use disorders","volume":"25","author":"Stetsiv","year":"2023","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.psychres.2026.117283_bib0046","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11126-020-09839-x","article-title":"Clozapine for treatment-refractory aggressive behavior","volume":"92","author":"Teodorescu","year":"2021","journal-title":"Psychiatr Q"},{"issue":"3","key":"10.1016\/j.psychres.2026.117283_bib0047","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.yco.0000218593.08313.fd","article-title":"Psychosis among substance users","volume":"19","author":"Thirthalli","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117283_bib0048","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40429-023-00528-w","article-title":"Substance-induced psychosis: a narrative review","volume":"11","author":"Toma\u0161i\u0107","year":"2024","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.psychres.2026.117283_bib0049","series-title":"World Drug Report 2025","year":"2025"},{"issue":"2","key":"10.1016\/j.psychres.2026.117283_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/brainsci10020097","article-title":"Factors moderating the association between Cannabis use and psychosis risk: a systematic review","volume":"10","author":"van der Steur","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.psychres.2026.117283_bib0051","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mp.2016.252","article-title":"Cannabis use and risk of schizophrenia: a mendelian randomization study","volume":"23","author":"Vaucher","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117283_bib0052","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41398-021-01330-w","article-title":"Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank","volume":"11","author":"Wainberg","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117283_bib0053","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41421-018-0060-z","article-title":"Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA","volume":"4","author":"Wei","year":"2018","journal-title":"Cell Discov."},{"key":"10.1016\/j.psychres.2026.117283_bib0054","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2017.11.001","article-title":"Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: a systematic review","volume":"197","author":"Wilson","year":"2018","journal-title":"Schizophr Res."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126003434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126003434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:27:49Z","timestamp":1792052869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126003434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S0165178126003434"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117283","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of onset and progression of psychoses induced by psychoactive substance use","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117283"}}